REGENERON PHARMACEUTICALS, INC. Active Patents
1,189 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-09-18: Application 19333265; Invention Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies; Applicant Regeneron Pharmaceuticals, Inc.; Status Patented Case.
- 2025-09-05: Application 19320739; Invention METHODS OF CHARACTERIZING AND PURIFYING VEGF RECEPTOR FUSION PROTEIN; Applicant Regeneron Pharmaceuticals, Inc.; Status Patented Case.
- 2025-07-15: Application 19270011; Invention TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE; Applicant Regeneron Pharmaceuticals, Inc.; Status Patented Case.
- 2025-04-04: Application 19170240; Invention METABOLICALLY OPTIMIZED CELL CULTURE; Applicant REGENERON PHARMACEUTICALS, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-18 | 19333265 | Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies | Regeneron Pharmaceuticals, Inc. | Patented Case | 2026-05-12 | 12624115 | US20260022183A1 | Daniel B. Dix Xiaolin Tang | United States United States | LI, RUIXIANG |
| 2025-09-05 | 19320739 | METHODS OF CHARACTERIZING AND PURIFYING VEGF RECEPTOR FUSION PROTEIN | Regeneron Pharmaceuticals, Inc. | Patented Case | 2026-08-25 | 12715905 | US20260001935A1 | Paul CONROY John CROWLEY Marguerita McCARTHY Kathleen O'DWYER Shunhai WANG Sisi ZHANG Yuetian YAN Tyler GREER Siobhan HOGAN Xiaojing ZHENG Hui XIAO Ning LI Lili GUO Yuan MAO Prerana MANTRI Evan KOUFOS Kathir MUTHUSAMY Nisha PALACKAL Erica PYLES | Ireland Ireland Ireland Ireland United States United States United States United States Ireland United States United States United States United States United States United States United States United States United States United States | MOAZZAMI, NAGHMEH NINA |
| 2025-07-15 | 19270011 | TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE | Regeneron Pharmaceuticals, Inc. | Patented Case | 2026-08-25 | 12716051 | US20250340832A1 | Amy S. Johnson Meghan E. Casey Shadia Oshodi Shawn Lawrence | United States United States United States United States | ARON, KIMBERLY A |
| 2025-04-04 | 19170240 | METABOLICALLY OPTIMIZED CELL CULTURE | REGENERON PHARMACEUTICALS, INC. | Patented Case | 2026-02-10 | 12545717 | US20250326820A1 | Shawn LAWRENCE Michelle LAFOND Ann KIM Amy S. JOHNSON Brandon VERES Mark CZETERKO Kristen WHALEN | United States United States United States United States United States United States United States | SHIBUYA, MARK LANCE |
| 2025-01-23 | 19035322 | N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES | Regeneron Pharmaceuticals, Inc. | Patented Case | 2026-06-09 | 12649796 | US20250171545A1 | Yang SHEN Ann-Hwee LEE Yan YANG Chia-Yang LIN | United States United States United States United States | HUYNH, PHUONG N |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |